| Literature DB >> 21204016 |
Abstract
Dysregulation of the Wnt pathway has been extensively studied in multiple diseases, including some angiogenic disorders. Wnt signaling activation is a major stimulator in pathological angiogenesis and thus, Wnt antagonists are believed to have therapeutic potential for neovascular disorders. Actually, some Wnt antagonists have been identified directly from the anti-angiogenic factor family. This review summarizes the recent progress toward understanding of the roles of Wnt pathway antagonists in angiogenic regulation and their mechanism of action, and exploring their therapeutic potential.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21204016 PMCID: PMC4875116 DOI: 10.1007/s13238-010-0112-0
Source DB: PubMed Journal: Protein Cell ISSN: 1674-800X Impact factor: 14.870